Hemogenyx Pharmaceuticals Valuation Multiples
Discover revenue and EBITDA valuation multiples for Hemogenyx Pharmaceuticals.
Hemogenyx Pharmaceuticals Overview
About Hemogenyx Pharmaceuticals
Hemogenyx Pharmaceuticals PLC is clinical-stage biotechnology focused on the discovery, development and commercialisation of innovative treatments relating to the treatment of blood cancers, certain solid cancers, autoimmune diseases, and viral infections. The products under development are designed to address a range of problems that occur with current standard of care treatments.
Founded
2013
HQ
Employees
16
Website
Financials (FY)
EV
$59M
Valuation Multiples
Start free trial
Hemogenyx Pharmaceuticals Financials
Hemogenyx Pharmaceuticals reported last fiscal year revenue of - and negative EBITDA of ($12M).
In the same fiscal year, Hemogenyx Pharmaceuticals generated ($1M) in gross profit, ($12M) in EBITDA losses, and had net loss of ($13M).
Hemogenyx Pharmaceuticals P&L
In the most recent fiscal year, Hemogenyx Pharmaceuticals reported revenue of - and EBITDA of ($12M).
Hemogenyx Pharmaceuticals is unprofitable as of last fiscal year, with gross margin of -, EBITDA margin of -, and net margin of -.
Financial data powered by Morningstar, Inc.
Hemogenyx Pharmaceuticals Stock Performance
Hemogenyx Pharmaceuticals has current market cap of $58M, and enterprise value of $59M.
Hemogenyx Pharmaceuticals' stock price is $8.57.
Hemogenyx Pharmaceuticals has an EPS (earnings per share) of $-1.94.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $59M | $58M | -3.1% | - | - | - | $-1.94 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialHemogenyx Pharmaceuticals Valuation Multiples
Hemogenyx Pharmaceuticals trades at (4.9x) EV/EBITDA.
Hemogenyx Pharmaceuticals Financial Valuation Multiples
As of August 14, 2026, Hemogenyx Pharmaceuticals has market cap of $58M and EV of $59M.
Hemogenyx Pharmaceuticals has a P/E ratio of (4.4x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Hemogenyx Pharmaceuticals Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Hemogenyx Pharmaceuticals Margins & Growth Rates
Hemogenyx Pharmaceuticals Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Hemogenyx Pharmaceuticals Operational KPIs
Hemogenyx Pharmaceuticals' revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.3M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
Hemogenyx Pharmaceuticals Competitors
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
This data is available for Pro users. Sign up to see all Hemogenyx Pharmaceuticals competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Hemogenyx Pharmaceuticals
| When was Hemogenyx Pharmaceuticals founded? | Hemogenyx Pharmaceuticals was founded in 2013. |
| Where is Hemogenyx Pharmaceuticals headquartered? | Hemogenyx Pharmaceuticals is headquartered in United Kingdom. |
| How many employees does Hemogenyx Pharmaceuticals have? | As of today, Hemogenyx Pharmaceuticals has over 16 employees. |
| Is Hemogenyx Pharmaceuticals publicly listed? | Yes, Hemogenyx Pharmaceuticals is a public company listed on London Stock Exchange. |
| What is the stock symbol of Hemogenyx Pharmaceuticals? | Hemogenyx Pharmaceuticals trades under HEMO ticker. |
| When did Hemogenyx Pharmaceuticals go public? | Hemogenyx Pharmaceuticals went public in 2015. |
| Who are competitors of Hemogenyx Pharmaceuticals? | Hemogenyx Pharmaceuticals main competitors include |
| What is the current market cap of Hemogenyx Pharmaceuticals? | Hemogenyx Pharmaceuticals' current market cap is $58M. |
| Is Hemogenyx Pharmaceuticals profitable? | No, Hemogenyx Pharmaceuticals is not profitable. |
| How many companies Hemogenyx Pharmaceuticals has acquired to date? | Hemogenyx Pharmaceuticals hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Hemogenyx Pharmaceuticals has invested to date? | Hemogenyx Pharmaceuticals hasn't invested in any companies yet (or none have been disclosed publicly). |
Lists including Hemogenyx Pharmaceuticals
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.